FACT announced on October 1st the launch of the FACT Community Accelerator Program © , a limited time offering available and administered through the FACT Consulting arm. Demand for immune effector cell (IEC) therapies is growing, and FACT continues to...
Kara Wacker, MBA, RAC Foundation for the Accreditation of Cellular Therapy United States FACT Chief Medical Officer Phyllis I. Warkentin, MD, FASTCT, Announces Retirement After 30 Years of Leadership FACT announced that Phyllis I. Warkentin, MD, FASTCT, founding leader and Chief...
Tuula Rintala European Society for Blood and Marrow Transplantation (EBMT) Spain The implementation of Regulation (EU) 2024/1 in August 2027 — the Substances of Human Origin (SoHO) Regulation — marks one of the most consequential shifts in the European regulatory landscape for...
Tuula Rintala Director, Quality of Care and Advocacy EBMT, European Society for Blood and Marrow Transplantation Spain CAR-T cell therapy has transformed the treatment landscape for patients with haematological malignancies, but its promise can only be fully realised when every healthcare...
Tuula Rinala Director, Quality of Care and Advocacy EBMT, European Society for Blood and Marrow Transplantation Barcelona, Spain As of 2 February 2026, the FACT-JACIE International Standards for Immune Effector Cells, Third Edition (IEC 3.1), are in effect — bringing with them a formal,...
Breann Weishaar, BS Foundation for the Accreditation of Cellular Therapy (FACT) United States FACT Education is heading into 2026 with momentum—and a milestone. After an incredible 2025 that saw more than 800 professionals trained through in-person and virtual programs, FACT now...
Linda Miller, MPA Foundation for the Accreditation of Cellular Therapy (FACT) United States This year marks a significant milestone for the Foundation for the Accreditation of Cellular Therapy (FACT): 30 years of advancing quality and patient safety in cellular therapy and...
David Schmahl, CEO Foundation for the Accreditation of Cellular Therapy (FACT) United States On behalf of FACT’s Board of Directors, volunteer leaders, and headquarters’ staff, I’m privileged to share with you highlights of our efforts and outcomes of the past year. The information is a...
Tuula Rintala Director, Quality of Care and Advocacy EBMT, European Society for Blood and Marrow Transplantation Barcelona, Spain It has now been nine months since the EBMT General Assembly, at the Annual Meeting in Florence, formally approved JACIE as an EBMT Working Party. While this...
Kara Wacker, MBA, RAC ISCT North America LRA Committee Foundation or the Accreditation of Cellular Therapy United States Tuula Rintala European Society for Blood and Marrow Transplantation (EBMT) Spain FACT and JACIE Publish Updates to Hematopoietic Cell Therapy and Immune Effector...